PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0041696|major depressive disorder |
| Sentences | 29 |
| PubMedID- 23733090 | Eeg alpha power as an intermediate measure between brain-derived neurotrophic factor val66met and depression severity in patients with major depressive disorder. |
| PubMedID- 25642009 | We tested whether initiator tendency, attachment anxiety, attachment avoidance, and marital satisfaction predicted improvement in depression for women with major depressive disorder enrolled in a depression treatment clinical trial (n = 17). |
| PubMedID- 23355785 | A bidirectional relationship exists between diabetes mellitus (dm) and major depressive disorder (mdd), with depression commonly reported in both type 1 dm (t1dm) and type 2 dm (t2dm), and depressive symptoms associated with a higher incidence of diabetes. |
| PubMedID- 24341899 | Alterations in serotonergic signaling are associated with the pathogenesis of depression in patients with major depressive disorder - findings that are clinically supported by the effect of selective serotonin reuptake inhibitors (ssris) in the treatment of depression. |
| PubMedID- 23465042 | Conclusion: this research presents new data regarding bont-a as a potential treatment to improve depression symptoms in patients with major depressive disorder. |
| PubMedID- 25884606 | We report a naturalistic 5-year follow up of five patients who received vns implant for resistant depression (3 patients with major depressive disorder and 2 with bipolar disorder). |
| PubMedID- 25548109 | depression in individuals with either major depressive disorder (mdd) or bipolar disorder (bd) is one of the leading causes of the global disease burden. |
| PubMedID- 21615899 | Methods: we used data of primary care respondents from the netherlands study of depression and anxiety with major depressive disorder in the past year (n = 478). |
| PubMedID- 24707177 | In particular, 30% of individuals complaining of gastrointestinal disturbances were depressed, and somatic complaints may be linked to an underlying psychiatric illness.32 a previous study has reported a positive association between the characteristics of somatic symptoms (number, frequency, and associated disability) and severity of depression in patients with major depressive disorder.33 in view of this, when assessing workers, such complaints should be interpreted as a possible “wake-up call” for depression. |
| PubMedID- 23021193 | The aim of the current study was to compare the volumes of brain regions previously implicated in depression among patients with melancholic major depressive disorder (mdd), patients with psychotic mdd and normal controls. |
| PubMedID- 23800573 | Methods: 48 t2dm (47.8% males, age 59.8 +/- 11.1, t2dm duration 9.5 +/- 6.5 years) who had a major depressive disorder diagnosed with a beck depression inventory (bdi) test score greater than 16 and confirmed with a structured interview, were prescribed citalopram 20mg once daily. |
| PubMedID- 20856249 | Persons who were in full remission of depression were diagnosed with major depressive disorder (mdd) somewhere in their lives, but had been free of depression and anxiety during at least 6 months. |
| PubMedID- 24678508 | Further, we chose icd-9-cm codes for major depression, including 296.2 with major depressive disorder single episode and 296.3 with major depressive disorder recurrent episode. |
| PubMedID- 21683174 | Objective: although many studies have researched adherence to pharmacotherapy among patients with major depressive disorder (mdd), the effects of chronic depression, anxiety comorbidities, migraine, and other factors on adherence have rarely been studied. |
| PubMedID- 21368424 | Objective: to investigate the association between health related quality of life (hrqol) and severity of depression in patients with major depressive disorder (mdd). |
| PubMedID- 25043294 | Although depression in major depressive disorder is associated with low serotonin transporter binding, animal models suggest that ifn-associated mood effects are linked to increased presynaptic serotonin transporter binding. |
| PubMedID- 23650447 | Most human pharmacologic investigations of depression start with criteria for major depressive disorder (mdd) from the diagnostic and statistical manual of mental disorders. |
| PubMedID- 23562618 | Primary outcome criterion was severity of treatment-resistant major depressive disorder as assessed with the montgomery-asberg depression rating scale. |
| PubMedID- 21308258 | Conclusion: during episodes of depression, individuals with major depressive disorder experience changes in posture and mild dissatisfaction with body image. |
| PubMedID- 24910934 | Objective: to determine whether a single treatment of botulinum toxin a in the forehead (glabellar) region can improve symptoms of depression in patients with major depressive disorder (mdd), as defined by dsm-iv criteria. |
| PubMedID- 26395901 | Objectives: to assess the effects - and review the acceptability - of ketamine and other glutamate receptor modulators in comparison to placebo (or saline placebo), other pharmacologically active agents, or electroconvulsive therapy (ect) in alleviating the acute symptoms of depression in people with unipolar major depressive disorder. |
| PubMedID- 22732135 | The large number of people who experience mild depressive symptoms account for more burden of depression than those with major depressive disorder [9], suggesting that new methods are needed and that they should focus on the early stages of depression. |
| PubMedID- 20670396 | [3] found that the degree of disability was related to severity of depression in patients with major depressive disorder (mdd). |
| PubMedID- 25722115 | One of the putative neurochemical biomarkers for depression in major depressive disorder (mdd) is reduced cerebral concentration of myo-inositol. |
| PubMedID- 24800081 | [39] reported that, during episodes of depression, individuals with major depressive disorder experience changes in posture and mild dissatisfaction with body image; this negative impact might be counterbalanced by the improvement in body flexibility. |
| PubMedID- 25061955 | The recovery of the cognitive deficits following clinical remission from depression may be associated with subtypes of major depressive disorder. |
| PubMedID- 21879634 | Self-reported inability to cry as a symptom of anhedonic depression in outpatients with a major depressive disorder. |
| PubMedID- 26467656 | Direct and indirect influences of childhood abuse on depression symptoms in patients with major depressive disorder. |
| PubMedID- 24787143 | Placebo on cognitive function and depression in adults with recurrent moderate-to-severe major depressive disorder (mdd) was evaluated. |
Page: 1